[ET Net News Agency, 22 October 2021] CSPC Pharmaceutical Group Limited (01093)
announced the results of its subsidiary CSPC Innovation Pharmaceutical Co., Ltd.
For the third quarter of 2021, net profit attributable to listed company's shareholders
was RMB80.98 million, a year-on-year increase of 4.22%. Revenue was RMB341.19 million, a
year-on-year decrease of 1.29%. (RC)